Literature DB >> 7776672

Cardiac transplant coronary artery disease. A multivariable analysis of pretransplantation risk factors for disease development and morbid events.

D C McGiffin1, T Savunen, J K Kirklin, D C Naftel, R C Bourge, T D Paine, C White-Williams, T Sisto, L Early.   

Abstract

Coronary artery disease after cardiac transplantation is a major obstacle to long-term survival. The development and progression of coronary artery disease after cardiac transplantation was analyzed in 217 consecutive patients undergoing transplantation. The actuarial freedom from any coronary artery disease (by angiography or autopsy) was 81% at 2 years and 20% at 8 years after transplantation. Coronary artery disease was more prevalent in male than female patients (30% versus 50% free of coronary artery disease at 5 years, p = 0.01). By multivariable analysis, pretransplantation risk factors identified for coronary artery disease included pretransplantation positive cytomegalovirus serologic status of the recipient (p = 0.002) and older donor age (p = 0.07). Progression of coronary artery disease was variable in both time of onset and rate. Earlier detection did not result in more rapid progression. Coronary events severe enough for retransplantation (n = 8) and/or death from coronary artery disease (n = 9) occurred in 15 patients, of whom four underwent retransplantation. The actuarial freedom from coronary events was 88% at 5 years and 79% at 8 years. By multivariable analysis, only male recipient (p = 0.05) was a risk factor for coronary events. Seven of the 15 patients (47%) with coronary events died suddenly of coronary artery disease without prior angiographic evidence of severe coronary disease. Coronary artery disease is progressive. Improved surveillance methods are required to detect the disease and institute timely intervention to prevent the occurrence of unanticipated death.

Entities:  

Mesh:

Year:  1995        PMID: 7776672     DOI: 10.1016/S0022-5223(95)70191-5

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  7 in total

Review 1.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 2.  The metabolic effects of cyclosporin and tacrolimus.

Authors:  P Marchetti; R Navalesi
Journal:  J Endocrinol Invest       Date:  2000 Jul-Aug       Impact factor: 4.256

3.  Organ donor management in Canada: recommendations of the forum on Medical Management to Optimize Donor Organ Potential.

Authors:  Sam D Shemie; Heather Ross; Joe Pagliarello; Andrew J Baker; Paul D Greig; Tracy Brand; Sandra Cockfield; Shaf Keshavjee; Peter Nickerson; Vivek Rao; Cameron Guest; Kimberly Young; Christopher Doig
Journal:  CMAJ       Date:  2006-03-14       Impact factor: 8.262

Review 4.  Management of hyperlipidaemia associated with heart transplantation.

Authors:  Klaus Wenke
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 5.  Cardiac allograft vasculopathy: the Achilles' heel of long-term survival after cardiac transplantation.

Authors:  Amandeep Dhaliwal; Vinay Thohan
Journal:  Curr Atheroscler Rep       Date:  2006-03       Impact factor: 5.113

Review 6.  Graft vessel disease following heart transplantation: a systematic review of the role of statin therapy.

Authors:  Robin Som; Peter J Morris; Simon R Knight
Journal:  World J Surg       Date:  2014-09       Impact factor: 3.352

7.  Organ retrieval and banking in brain dead trauma patients: Our experience at level-1 trauma centre and current views.

Authors:  Chhavi Sawhney; Manpreet Kaur; Sanjeev Lalwani; Babita Gupta; Ira Balakrishnan; Aarti Vij
Journal:  Indian J Anaesth       Date:  2013-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.